SCHEMBL26499303

SCHEMBL26499303

O=c1n(-c2ccc(Cl)cc2)cnn1CCN1CCOCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 1/20 0.46
SIGMAR1 Q99720 1/20 0.44
HTR1A P08908 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
KCNH2 Q12809 1/20 0.43
CD274 Q9NZQ7 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
MCHR1 Q99705 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
CNR1 P21554 1/20 0.41
ABCB1 P08183 2/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPK1 P28482 2/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
NR2F2 P24468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26499316 0.94 KMT2A (0.44) ALDH1A1KMT2AMAPTSIGMAR1HTR1A
SCHEMBL26499306 0.88 DRD2 (0.51) ALDH1A1SIGMAR1KCNH2CYP2C19MCHR1
SCHEMBL26499309 0.81 KCNH2 (0.47) KMT2AHTR1AKCNH2MCHR1KDM4E
SCHEMBL26499319 0.77 PPARD (0.46) ALDH1A1MAPTPPARGPPARDPPARA
SCHEMBL26499297 0.77 MAPT (0.47) ALDH1A1MAPTMCHR1TSHRPPARG
SCHEMBL11973435 0.76 CYP2D6 (0.45) ALDH1A1HTR1ASMN1; SMN2KDM4EHPGD
SCHEMBL26499313 0.75 PPARD (0.45) MAPTMCHR1PPARGPPARDPPARA
SCHEMBL22349797 0.74 PPARD (0.48) ALDH1A1KMT2AMAPTSMN1; SMN2KDM4E
SCHEMBL31548631 0.72 HTR1A (0.45) ALDH1A1SIGMAR1HTR1AKCNH2MCHR1
SCHEMBL31548630 0.72 HTR1A (0.45) ALDH1A1SIGMAR1HTR1AKCNH2MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230321082-A1 USE OF TRIAZOLE ANALOGUES FOR INHIBITION OF A TRIPARTITE VOR PROTEIN COMPLEX IN MULTICELLULAR ORGANISMS BOE TECHNOLOGY GROUP CO., LTD. (CN) 2023-10-12 US disclosed
US-20230321082-A1 USE OF TRIAZOLE ANALOGUES FOR INHIBITION OF A TRIPARTITE VOR PROTEIN COMPLEX IN MULTICELLULAR ORGANISMS BOE TECHNOLOGY GROUP CO., LTD. (CN) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230321082-A1 USE OF TRIAZOLE ANALOGUES FOR INHIBITION OF A TRIPARTITE VOR PROTEIN COMPLEX IN MULTICELLULAR ORGANISMS RABL3, VAPA, VAPB ALDH1A1 4596/4885KMT2A 4618/4885MAPT 1524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.